rituximab

The drug is indicated for the treatment of severe alopecia areata in adults and children aged 12 years and older.

Form: capsules, hard

ATC: L04AF08

Manufacturer: Pfizer Inc. (stability testing)

The drug is used for the treatment of follicular non-Hodgkin lymphoma (both in combination with chemotherapy and for maintenance therapy), as well as for the treatment of CD20-positive diffuse large B-cell non-Hodgkin lymphoma.

Form: solution for injection

ATC: L01FA01

Manufacturer: F. Hoffmann-La Roche Ltd (manufacturing of unpackaged products, primary and secondary packaging, quality control testing, batch release)

The drug is used to treat certain types of non-Hodgkin lymphoma, chronic lymphocytic leukemia, rheumatoid arthritis, as well as granulomatosis with polyangiitis and microscopic polyangiitis.

Form: concentrate for infusion solution

ATC: L01FA01

Manufacturer: F. Hoffmann-La Roche Ltd (secondary packaging, quality control testing, batch release)

The drug is used to treat certain types of blood cancer, specifically non-Hodgkin lymphomas and chronic lymphocytic leukemia. It is also used to induce remission in severe forms of granulomatosis with polyangiitis and microscopic polyangiitis.

Form: concentrate for infusion solution

ATC: L01XC02

Manufacturer: Dr. Reddy's Laboratories Ltd

The drug is used to treat non-Hodgkin lymphomas (specifically follicular and diffuse large B-cell lymphoma), chronic lymphocytic leukemia, granulomatosis with polyangiitis, microscopic polyangiitis, pemphigus vulgaris, and severe rheumatoid arthritis.

Form: concentrate for infusion solution

ATC: L01FA01

Manufacturer: Sandoz GmbH - Business Unit Technological Development and Manufacturing of Biological Medicinal Products Schaftlach (BTDM DPS) (manufacturer responsible for batch release)

The drug is used to treat various types of non-Hodgkin lymphomas, chronic lymphocytic leukemia, granulomatosis with polyangiitis, microscopic polyangiitis, pemphigus vulgaris, and severe rheumatoid arthritis.

Form: concentrate for infusion solution

ATC: L01FA01

Manufacturer: Sandoz GmbH – Production Unit Aseptic Medicinal Products Schaftlach (Aseptic MPS) (batch release)

The drug is prescribed to adults for the treatment of non-Hodgkin lymphomas (follicular and diffuse large B-cell), chronic lymphocytic leukemia, severe rheumatoid arthritis, as well as granulomatosis with polyangiitis and microscopic polyangiitis. In children from 6 months to 18 years of age, it is indicated for certain forms of non-Hodgkin lymphoma.

Form: concentrate for infusion solution

ATC: L01FA01

Manufacturer: Celltrion Inc. (manufacturing, primary packaging, secondary packaging, stability testing)